Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable …
Over the last 12 months, insiders at Lantheus Holdings, Inc. have bought $0 and sold $19.54M worth of Lantheus Holdings, Inc. stock.
On average, over the past 5 years, insiders at Lantheus Holdings, Inc. have bought $141,200 and sold $13.07M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $18,600 was made by Maeusli Heinz Christoph (director) on 2021‑03‑05.
2024-11-15 | Sale | CFO and Treasurer | 10,000 0.0143% | $81.20 | $812,000 | +17.49% | ||
2024-11-14 | Sale | President | 2,000 0.0028% | $79.65 | $159,300 | 0.00% | ||
2024-11-08 | Sale | director | 11,487 0.0167% | $87.16 | $1M | +2.32% | ||
2024-08-21 | Sale | director | 1,000 0.0014% | $98.52 | $98,520 | +4.07% | ||
2024-08-14 | Sale | See Remarks | 2,500 0.0036% | $97.54 | $243,850 | 0.00% | ||
2024-08-12 | Sale | director | 15,500 0.0223% | $96.48 | $1.5M | +8.62% | ||
2024-08-08 | Sale | President | 2,000 0.0028% | $96.39 | $192,780 | +7.36% | ||
2024-08-02 | Sale | director | 10,481 0.0148% | $95.50 | $1M | +4.63% | ||
2024-07-16 | Sale | Chief Accounting Officer | 1,796 0.0041% | $124.96 | $224,423 | -11.40% | ||
2024-07-15 | Sale | Chief Accounting Officer | 341 0.0008% | $123.15 | $41,994 | 0.00% | ||
2024-07-10 | Sale | director | 12,530 0.0219% | $95.04 | $1.19M | 0.00% | ||
2024-06-13 | Sale | Chief Accounting Officer | 341 0.0005% | $79.77 | $27,202 | +26.87% | ||
2024-05-31 | Sale | President | 1,179 0.0017% | $80.82 | $95,287 | +20.52% | ||
2024-05-30 | Sale | See Remarks | 12,873 0.0184% | $79.86 | $1.03M | +22.38% | ||
2024-05-28 | Sale | director | 2,500 0.0036% | $78.50 | $196,250 | +23.67% | ||
2024-05-28 | Sale | director | 18,373.33 0.0264% | $79.19 | $1.45M | +23.67% | ||
2024-05-13 | Sale | Chief Accounting Officer | 341 0.0005% | $76.89 | $26,219 | +24.47% | ||
2024-04-15 | Sale | Chief Accounting Officer | 341 0.0005% | $61.24 | $20,883 | +51.03% | ||
2024-03-15 | Sale | CFO and Treasurer | 20,000 0.0301% | $60.00 | $1.2M | +52.88% | ||
2024-03-13 | Sale | Chief Accounting Officer | 341 0.0005% | $60.48 | $20,624 | +48.53% |
Maeusli Heinz Christoph | director | 23340 0.0336% | $92.45 | 8 | 1 | +41.74% |
BlackRock | $524.83M | 12.17 | 8.43M | -0.41% | -$2.14M | 0.01 | |
The Vanguard Group | $458.27M | 10.62 | 7.36M | +5.59% | +$24.26M | 0.01 | |
Janus Henderson | $238.95M | 5.54 | 3.84M | -2.75% | -$6.74M | 0.12 | |
State Street | $154.96M | 3.59 | 2.49M | +3.79% | +$5.66M | 0.01 | |
Westfield Capital Management Co Lp | $121.87M | 2.83 | 1.96M | +25.26% | +$24.57M | 0.64 |